product Name:Efrotomycin
  • Efrotomycin [USAN:INN:BAN]; (alphaS,2R,3R,4R,6S)-4-((6-Deoxy-4-O-(6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)-3-O-methyl-beta-D-allopyranosyl)oxy)-N-((2E,4E,6S,7R)-7-((2S,3S,4R,5R)-5-((1E,3E,5E)-6-(1,2-dihydro-4-hydroxy-1-methyl-2-oxonicotinoyl)-1,3,5-heptatrienyl)tetrahydro-3,4-dihydroxy-2-furyl)-6-methoxy-5-methyl-2,4-octadienyl)-alpha-ethyltetrahydro-2,3-dihydroxy-5,5-dimethyl-6-((1E,3Z)-1,3-pentadienyl)-2H-pyran-2-acetamide; Antibiotic FR 02A; BRN 5230192; Efrotomicina; Efrotomicina [Spanish]; Efrotomycine; Efrotomycine [French]; FR 02A; MK-621; Mocimycin, 31-O-(6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)-3-O-methyl-beta-D-allopyranosyl)-1-methyl-; Producil; UNII-5BPJ82Q45X
  • 56592-32-6
  • C60H93NO20
  • 1148.3751
  • InChI=1/C60H93NO20/c1-15-17-19-27-40-59(9,10)55(80-57-47(68)52(74-13)51(36(8)76-57)79-58-53(75-14)46(67)50(73-12)35(7)77-58)54(69)60(71,81-40)37(16-2)56(70)61-30-23-22-25-33(5)48(72-11)34(6)49-45(66)44(65)39(78-49)26-21-18-20-24-31(3)42(63)41-38(62)29-28-32(4)43(41)64/h15,17-27,32,34-41,44-55,57-58,62,65-69,71H,16,28-30H2,1-14H3,(H,61,70)/b17-15+,20-18+,23-22+,26-21+,27-19+,31-24+,33-25+/t32?,34-,35+,36-,37-,38?,39-,40+,41?,44+,45+,46-,47-,48-,49+,50+,51-,52+,53-,54-,55+,57+,58+,60-/m1/s1
  • Efrotomycin 56592-32-6
  • 1.574